Veralto (VLTO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Achieved full-year 2024 sales of $5,193 million, with 3.7% core sales growth driven by balanced volume and price contributions, and strong execution in both business segments.
Q4 2024 sales reached $1,345 million, up 4.4% year-over-year, with core sales growth of 4.6% and robust free cash flow conversion.
Adjusted EPS for 2024 increased 11% to $3.54, exceeding initial guidance, with double-digit growth and margin expansion.
Strengthened portfolio through the acquisition of TraceGains, a minority investment in Axine Water Technologies, and the divestiture of AVT, enhancing digital and recurring revenue streams.
Disciplined capital allocation included a 22% dividend increase and strategic M&A activity.
Financial highlights
FY 2024 total sales grew 3.4% year-over-year to $5,193 million, with 3.7% core sales growth and 80 basis points of adjusted operating profit margin expansion.
Adjusted operating profit for 2024 was $1,251 million (24.1% margin); adjusted EPS was $3.54, up 11% year-over-year.
Free cash flow for 2024 was $820 million, with 98% conversion and $1,101 million cash on hand at year-end.
Q4 2024 adjusted EPS was $0.95, up 9% year-over-year; free cash flow was $263 million.
Q4 2024 gross profit margin improved 170 basis points year-over-year to 59.6%.
Outlook and guidance
FY 2025 guidance targets low- to mid-single-digit core sales growth, 25–50 basis points of adjusted operating profit margin improvement, and adjusted EPS of $3.60–$3.70 per share.
Free cash flow conversion for 2025 is expected at 90%–100% of GAAP net income, with CapEx at 1%–1.5% of sales.
Q1 2025 guidance: core sales growth in low- to mid-single digits, adjusted EPS of $0.84–$0.88, and operating margin of 24%–24.5%.
Currency is expected to be a 2% headwind to sales and $0.08 headwind to adjusted EPS.
Latest events from Veralto
- Record 2025 growth and cash flow, with 2026 set for further gains and margin expansion.VLTO
Q4 20254 Feb 2026 - Q1 2025 saw 6.9% sales growth, margin gains, and robust segment results, with guidance reaffirmed.VLTO
Q1 20253 Feb 2026 - Q2 sales up 2.8%, core sales up 3.8%, margins expanded, and full-year EPS guidance raised.VLTO
Q2 20242 Feb 2026 - Q3 sales and EPS grew, margins expanded, and TraceGains acquisition strengthened digital offerings.VLTO
Q3 202418 Jan 2026 - Annual meeting covers director elections, governance reforms, and strong 2024 results.VLTO
Proxy Filing2 Dec 2025 - 2024 saw strong growth, governance enhancements, and major ESG progress, with key votes ahead.VLTO
Proxy Filing2 Dec 2025 - Key proposals include director elections, auditor ratification, and governance enhancements.VLTO
Proxy Filing2 Dec 2025 - Sales and earnings grew strongly, prompting a raised full-year outlook and guidance.VLTO
Q2 20253 Nov 2025 - Q3 2025 saw strong sales, EPS, and cash flow growth, with raised full-year guidance.VLTO
Q3 202529 Oct 2025